ABC | Volume 114, Nº2, Fevereiro 2020

Artigo Original Gonçalves et al. Previsão do TECP em pacientes com IC e FA Arq Bras Cardiol. 2020; 114(2):209-218 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 24. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Mabuchi N, Hayashi M, et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur Heart J. 1999;20(24):1799-807. 25. Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J. 2003;24(19):1735-43. 26. Arena R, Guazzi M, Myers J, Peberdy MA. Prognostic value of heart rate recovery in patients with heart failure. AmHeart J. 2006;151(4):851 e7-13. 27. Jackson CE, Castagno D, Maggioni AP, Kober L, Squire IB, Swedberg K, et al. Differing prognostic value of pulse pressure in patients with heart failurewith reduced or preserved ejection fraction: results from theMAGGIC individual patient meta-analysis. Eur Heart J. 2015;36(18):1106-14. 28. Cleland JGF, Bunting KV, Flather MD, Altman DG, Holmes J, Coats AJS, et al. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials. Eur Heart J. 2018;39(1):26-35. 29. Kotecha D, Flather MD, Altman DG, Holmes J, Rosano G, Wikstrand J, et al. Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure. J Am Coll Cardiol. 2017;69(24):2885-96. 30. Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG, et al. Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient datameta-analysis. Lancet. 2014;384(9961):2235-43. 31. Buller NP, Poole-Wilson PA. Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure. Br Heart J. 1990;63(5):281-3. 32. Francis DP, Shamim W, Davies LC, Piepoli MF, Ponikowski P, Anker SD, et al. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). Eur Heart J. 2000;21(2):154-61. 33. Corra U, Mezzani A, Bosimini E, Scapellato F, Imparato A, Giannuzzi P. Ventilatory response to exercise improves risk stratification in patients with chronic heart failure and intermediate functional capacity. Am Heart J. 2002;143(3):418-26. 34. Tabet JY, Beauvais F, Thabut G, Tartiere JM, Logeart D, Cohen-Solal A. A critical appraisal of the prognostic value of the VE/VCO2 slope in chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2003;10(4):267-72. 35. Arena R, Myers J, Abella J, Peberdy MA, Bensimhon D, Chase P, et al. Development of a ventilatory classification system in patients with heart failure. Circulation. 2007;115(18):2410-7. 36. Elshazly MB, Senn T, Wu Y, Lindsay B, Saliba W, Wazni O, et al. Impact of atrial fibrillation on exercise capacity and mortality in heart failure with preserved ejection fraction: insights from cardiopulmonary stress testing. J AmHeart Assoc. 2017;6(11):pii: e006662. 37. AgostoniP,EmdinM,CorraU,VegliaF,MagriD,TedescoCC,etal.Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. Eur Heart J. 2008;29(19):2367-72. 38. Tsuneoka H, Koike A, Nagayama O, Sakurada K, Kato J, Sato A, et al. Prognostic value of cardiopulmonary exercise testing in cardiac patients with atrial fibrillation. Int Heart J. 2012;53(2):102-7. 39. Stelken AM, Younis LT, Jennison SH, Miller DD, Miller LW, Shaw LJ, et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol. 1996;27(2):345-52. 40. Baba R, NagashimaM, GotoM, Nagano Y, YokotaM, Tauchi N, et al. Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol. 1996;28(6):1567-72. 41. Van LaethemC, Van De Veire N, De Backer G, Bihija S, Seghers T, Cambier D, et al. Response of the oxygen uptake efficiency slope to exercise training in patients with chronic heart failure. Eur J Heart Fail. 2007;9(6-7):625-9. 42. Davies LC, Wensel R, Georgiadou P, Cicoira M, Coats AJ, Piepoli MF, et al. Enhancedprognosticvalue fromcardiopulmonaryexercisetesting inchronic heart failure by non-linear analysis: oxygen uptake efficiency slope. Eur Heart J. 2006;27(6):684-90. 43. Arena R, Myers J, Hsu L, Peberdy MA, Pinkstaff S, Bensimhon D, et al. The minute ventilation/carbon dioxide production slope is prognostically superior to the oxygen uptake efficiency slope. J Card Fail. 2007;13(6):462-9. 44. Chua TP, Ponikowski P, HarringtonD, Anker SD,Webb-Peploe K, Clark AL, et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J AmColl Cardiol. 1997;29(7):1585-90. 45. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991;83(3):778-86. 218